secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cellectar Biosciences, Inc. (CLRB)
CIK:        0001279704
Form:       8-K
Filed at:   2023-11-29T23:59:59+00:00
Accession:  0001104659-23-122057
Event type: regulatory
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Cellectar regains Nasdaq compliance via $35M+ market value of listed securities
-------------------------------------------------------------------------------

- Nasdaq notified Cellectar on Nov 21, 2023, that it meets the $35M minimum market value of listed securities under Rule 5550(b)(2), resolving the deficiency.
- Prior deficiency: stockholders' equity was $(467,000) as of June 30, 2023, below the $2.5M minimum required under Rule 5550(b)(1).
- The company had been at risk of delisting since August 16, 2023; compliance is now fully restored.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1279704/000110465923122057/0001104659-23-122057-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1279704/000110465923122057/tm2331790d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-122057

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer